The epidermal growth factor receptor (EGFR) and its ligand transforming growth factor (TGF)
alpha are hypothesized to form an autocrine growth loop in non-small cell lung cancer …

The epidermal growth factor receptor (EGFR) and one of its ligands, transforming growth
factor α (TGF-α), are thought to function as a potential autocrine loop in non-small cell lung …

Immunohistochemical study of epidermal growth factor (EGF), epidermal growth factor
receptor (EGFR) and transforming growth factor-alpha (TGF-alpha) expression was …

A total of 152 non-small cell lung cancers (NSCLC) were studied retrospectively to
determine the relationship between epidermal growth factor receptor (EGF-R) status and the …

BACKGROUND Recently, molecular therapies targeting epidermal growth factor receptor
(EGFR) have been developed for clinical use. The current study was conducted to determine …

Epidermal growth factor receptor (EGFR) is commonly overexpressed in non-small cell lung
cancer (NSCLC) and its tyrosine kinase phosphorylation is thought to be an ideal target in …

Epidermal growth factor receptor (EGFR) overexpression in nonsmall cell lung carcinomas
(NSCLC) is variable ranging from 19% to 89% and its prognostic value remains …

Sixty-three primary lung carcinomas were examined immunohistochemically for the
presence of epidermal growth factor receptors (EGF-R). Of these tumors 35 (55.5%) were …

The epidermal growth factor receptor is homologous to the oncogene erb-beta and is the
receptor for a class of tumour growth factors (TGF-alpha). The clinical correlations with its …

Epidermal growth factor receptor (EGFR) was measured using a competitive radioligand
binding assay in membrane preparations from 74 primary human non-small cell lung cancer …